Shanghai Bio-Heart Announces Director Changes

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185) has released an update.

Shanghai Bio-Heart Biological Technology Co., Ltd. has announced the resignation of its independent non-executive directors, Mr. Charles Chan and Mr. Wing Yiu Djen, who are stepping down to focus on their other work commitments. The company has proposed the appointment of Mr. Yiqing Chen and Mr. Yifei Jiang as their replacements, pending shareholder approval at the upcoming AGM. The board expressed its appreciation for the valuable contributions of the departing directors and provided detailed biographies for the nominees, highlighting their extensive experience in finance and business management.

For further insights into HK:2185 stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.